Effectiveness of varenicline and counselling for smoking cessation in an observational cohort study in China

BMJ Open

Volumn 6, Issue 1, 2016, Pages

  Jiang, Bin ^a   He, Yao ^a   Zuo, Fang ^a   Wu, Lei ^a   Liu, Qing Hui ^a   Zhang, Li ^a   Zhou, Chang Xi ^a   Cheng, K K ^b   Chan, Sophia S C ^c   Lam, Tai Hing ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

VARENICLINE; NICOTINIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; COHORT ANALYSIS; COUGHING; COUNSELING; DIARRHEA; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FLATULENCE; FOLLOW UP; HEART PALPITATION; HIP CIRCUMFERENCE; HUMAN; INSOMNIA; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NICOTINE REPLACEMENT THERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PRURITUS; SECONDARY ANALYSIS; SELF CARE; SELF REPORT; SLEEP DISORDER; SMOKING CESSATION; STRUCTURED QUESTIONNAIRE; TOBACCO DEPENDENCE; TOBACCO USE; XEROSTOMIA; CLINICAL TRIAL; MIDDLE AGED; OUTPATIENT DEPARTMENT; PHYSICIAN; PROCEDURES; QUESTIONNAIRE; SMOKING; TOBACCO USE DISORDER; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE FACILITIES; BEIJING; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; PHYSICIANS; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES; TOBACCO USE DISORDER; TREATMENT OUTCOME; VARENICLINE;

EID: 84960171879     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-009381     Document Type: Article

References (27)

1. Kaleta D, Koziel = A, Mis̈kiewicz P. MPOWER-strategy for fighting the global tobacco epidemic. Med Pr 2009;60:145-9.
2. Li Q, Hsia J, Yang GH. Prevalence of smoking in China in 2010. N Engl J Med 2011;364:2469-70.
3. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, versus sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296:47-55.
4. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, versus placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296:56-63.
5. Wang C, Xiao D, Chan KP, et al. Varenicline for smoking cessation: A placebo-controlled, randomized study. Respirology 2009;14:384-92.
6. Tsai ST, Cho HJ, Cheng HS, et al. A randomized, placebo-controlled trial of varenicline, a selective a4b2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. Clin. Ther 2007;29:1027-39.
7. Nakamura M, Oshima A, Fujimoto Y, et al. Efficacy and tolerability of varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther 2007;29:1040-56.
8. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;4: CD006103.
9. Yang G, Ma J, Chen A, et al. Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control 2001;10:170-4.
10. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004;99:29-38.
11. Wang C, Cho B, Xiao D, et al. Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice. Int J Clin Pract 2013;67:469-76.
12. Abdullah AS, Hedley AJ, Chan SS, et al, Hong Kong Council on Smoking and Health Smoking Cessation Health Centre (SCHC) Steering Group. Establishment and evaluation of a smoking cessation clinic in Hong Kong: a model for the future service provider. J Public Health (Oxf) 2004;26:239-44.
13. He Y, Lam TH, Jiang B, et al. Study design and the preliminary results on the modes of smoking cessation in general hospitals. Chin J Epidemiol 2011;32:192-5.
14. Lam TH, Abdullah AS, Chan SS, et al. Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Psychopharmacology (Berl) 2005;177:400-8.
15. Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J 1990;69:763-5.
16. Zhu WH, Yang L, Jiang CQ, et al. Characteristics of smokers and predictors of qutting in a smoking cessation clinic in Guangzhou, China. J Public Health (Oxf) 2010;32:267-76.
17. Prochaska JO, Goldstein MG. Process of smoking cessation. Implications for clinicians. Clin Chest Med 1991;12:727-35.
18. Fiore MC. US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care 2000;45:1200-62.
19. Liang DH, Liu H, Wei CZ. Clinical observation of varenicline for smoking cessation. Chin J New Clin Med 2011;4:1161-2.
20. Dhelaria RK, Friderici J, Wu K, et al. Effectiveness of varenicline for smoking cessation at 2 urban academic health centers. Eur J Intern Med 2012;23:461-4.
21. Blak BT, Wilson K, Metcalfe M, et al. Evaluation of varenicline as an aid to smoking cessation in UK general practice-a THIN database study. Curr Med Res Opin 2010;26:861-70.
22. Andreas S, Chenot JF, Diebold R, et al. Effectiveness of Varenicline as an Aid to Smoking Cessation in Primary Care: An Observational Study. Eur Addict Res 2013;19:47-54.
23. Boudrez H, Gratziou C, Messig M, et al. Effectiveness of varenicline as an aid to smoking cessation: Results of an inter-European observational study. Curr Med Res Opin 2011;27:769-75.
24. Razavi D, Vandecasteele H, Primo C, et al. Maintaining abstinence from cigarette smoking: effectiveness of group counselling and factors predicting outcome. Eur J Cancer 1999;35:1238-47.
25. Hyland A, Li Q, Bauer JE, et al. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res 2004;6(Suppl 3):S363-9.
26. Hymowitz N, Cummings KM, Hyland A, et al. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997;6(Suppl. 2):S57-62.
27. Ebbert JO, Hughes JR, West RJ, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA 2015;313:687-94.